CLINICAL_TRIALS trial_result · 2017-10-02

Clinical Trial Update: A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS) [Phase 1]

Phase 1 pilot trial evaluating inosine in people with amyotrophic lateral sclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Massachusetts General Hospital | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED | Results posted: 2017-10-02